New drug cocktail aims to fight Hard-to-Treat sarcomas
Disease control
Terminated
This phase 2 trial tests a combination of two drugs—fruquintinib (which blocks blood vessel growth) and envafolimab (an immunotherapy)—in 20 people with advanced or unresectable bone and soft tissue sarcoma. The goal is to see if the combo can slow tumor growth or shrink tumors. …
Phase: PHASE2 • Sponsor: Shanghai 6th People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC